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regulated by wild and mutant HBx, demonstrated a lower
level in the LO2/HBx-d382 cell. Further characterization of
miR-338 3p revealed that it negatively regulated cellular
proﬁleration. Cell cycle analysis showed that miR-338 3p
induced cell cycle arrest at the G1/S phase. A dual-
luciferase reporter assay demonstrated that the 3′UTR of
CyclinD1 were directly bound to miR-338 3p and western
blotting analysis further indicated that miR-338 3p down-
regulated the expression of CyclinD1.
Conclusion: This study demonstrates that HBx can
inﬂuence cellular miRNA expression. The deregulation of
the expression of miR-338 3p by HBx may represent a
potential novel pathway which HBx acts to deregulate cell
proliferation leading to hepatocarcinogenesis.
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Objective: The aim of this study was to investigate the
relationship between HBsAg, HBcAg expression and serum
HBV DNA level.
Methods: The expression of HBsAg, HBcAg in the livers
of 140 patients with chronic hepatitis B was detected by
immunohistochemistry. And the level of serum hepatitis B
virus DNA (HBV DNA) was tested. Statistical signiﬁcance was
assessed using One-Way analysis of variance (ANOVA).
Results: Serum HBV DNA level in 13 patients with
HBsAg ( ~±), 108 patients with (+~++) and 19 patients
with (+++~++++) was 5.313±1.874 copies log10/ml,
6.010±2.016 copies log10/ml and 5.664±1.548 copies
log10/ml respectively (P= 0.408). Serum HBV DNA level in
42 patients with HBsAg ( ~±), 79 patients with (+~++)
and 19 patients with (+++~++++) was 5.886±1.997 copies
log10/ml, 5.968±2.020 copies log10/ml and 5.634±1.551
copies log10/ml respectively (P= 0.800).
Conclusions: The expression of HBsAg, HBcAg in the liver
does not correlate with serum HBV DNA level.
PP-107 Cause analysis of chronic HBV infected patients
without antiviral therapy in the Pearl River
Delta region
G.L. Lin1 *, X.J. Zhang1, Y. Yan1, Y.K. Wu1, X.Y. Li1,
L.Q. Yang1, Y.T. Chong1. 1The third afﬁliated hospital of
Sun Yat-sen University, China
Objectives: To analyze the causes of the patients with
chronic Hepatitis B without taking antiviral therapy and the
strategies of dealing with it.
Method: We make long-termed observation on the patients
with chronic Hepatitis B Virus (HBV) infection, who were
voluntarily to be followed up in our clinic department, and
analyze statistically the objective and subjective causes of
patient without taking antiviral therapy.
Results: In total eligible 951 cases, 424 cases didn’t
receive the antiviral therapy. 105 out of 424 cases had the
indications of the antiviral therapy (105/424, 24.8%), the
other 319 cases had no indications of the therapy (319/424,
75.2%). The ratio of female (124/202, 61.4%) who didn’t
get the antiviral therapy was signiﬁcant higher than that
of male (300/749, 40.0%). 49 out of 105 cases who had
the indications of the antiviral therapy worried about the
unhealthful effect on their fertility by the antiviral drugs
and put off antiviral therapy (49/105, 46.7%); 31out of
105 cases could not pay for the antiviral therapy (31/105,
29.5%); 19 out of 105 cases queried the safety of the
antiviral drugs and uncertainty of course of the treatment
(19/105, 18.1%). 6 out of 105 cases were because of poor
compliance (6/105, 5.7%).
Conclusions: No antiviral indications was the main cause
of the untreated group. The causes of that patients
with indications didn’t receive antiviral therapy were
that worrying about their fertility, fees of the treatment
hard to bear, querying the safety of the antiviral drugs
and uncertainty of course of the treatment, and poor
compliance. Formal long-termed follow up by the clinicians,
good communications between clinicians and patients and
health education might improve the effects of anti-HBV
treatment.
PP-108 Investigation on serum HBV viral loads and
the changes of liver pathological features in
158 patients with chronic hepatitis B
Y. Yan1 *, L. Mai1, J. Liu1, J.Y. Zhu1, Y. Zhang1. 1The Third
Afﬁliated Hospital of Sun Yat-sen University, China
Objective: To investigate the relationship between serum
HBV DNA loads and liver pathological changes in the patients
with chronic hepatitis B.
Methods: The relationship among HBV DNA loads, live
histological inﬂammation grades and ﬁbrosis stages of
158 cases was analyzed.
Results: The serum HBV DNA loads in HBeAg-positive group
with inﬂammation grades G0 1 (6 patients), G2 (74 patients)
and G3 4 (25 patients) were 5.580±1.098 copies log10/ml,
6.520±2.004 copies log10/ml and 6.950±1.467 copies
log10/ml respectively. There was no signiﬁcant difference
in patients of three inﬂammation grades (P= 0.250). The
serum HBV DNA loads in HBeAg-positive group with liver
tissues ﬁbrosis stages of S0 1 (23 patients), S2 (56 patients),
S3 4 (26 patients) were 6.599±1.832 copies log10/ml,
6.559±2.012 copies log10/ml, 6.562±1.601 copies log10/ml
respectively, the difference was not signiﬁcant (P= 0.996).
The serum HBV DNA loads in HBeAg-negative group with
inﬂammation grades G0 1 (8 patients), G2 (17 patients)
and G3 4 (28 patients) were 2.132±1.875 copies log10/ml,
4.745±2.250 copies log10/ml and 5.581±2.305 copies
log10/ml respectively. The serum HBV DNA level in patients
with G2 and G3 4 inﬂammation grades was signiﬁcant
higher than in patients with G0 1 inﬂammation grades
(P= 0.001). The serum HBV DNA loads in HBeAg-negative
group with liver tissues ﬁbrosis stages of S0 1 (10 patients),
S2 (45 patients), S3 4 (18 patients) were 2.689±3.225 copies
log10/ml, 5.127±1.833 copies log10/ml, 5.375±2.410 copies
log10/ml respectively. The serum HBV DNA level in patients
with ﬁbrosis stages of S2 and S3 4 was signiﬁcant higher than
in patients with ﬁbrosis stages of S0 1 (P = 0.005).
Conclusions: The serum HBV DNA level does not correlate
with the inﬂammation grades and ﬁbrosis stages of liver
tissues in HBeAg-positive patients. The serum HBV DNA
loads display a positive correlation with the inﬂammation
grades and ﬁbrosis stages of liver tissues in HBeAg-negative
patients.
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Objectives: Hepatitis B Virus (HBV) infection is a primary
risk factor for hepatocellular carcinoma (HCC), the ﬁfth
most frequent cancer, worldwide. The present study was
undertaken to analyze the association of IL-6 ( 572) and
